Fri. 10 May 2024, 8:33am ET
Benzinga
Earnings, News
Checkpoint Therapeutics (NASDAQ:CKPT) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of $(0.27) by 22.22 percent. This is a 62.92 percent increase over losses of $(0.89) per share from the same period last year.